TY - JOUR
T1 - Effects of intranasally-delivered pro-nerve growth factors on the septo-hippocampal system in healthy and diabetic rats
AU - Soligo, Marzia
AU - Protto, Virginia
AU - Chiaretti, Antonio
AU - Piccinin, Sonia
AU - De Stefano, Maria Egle
AU - Nisticò, Robert
AU - Bracci-Laudiero, Luisa
AU - Manni, Luigi
PY - 2020
Y1 - 2020
N2 - Pro-nerve growth factor (proNGF) is the predominant form of NGF in the brain and its levels increase in neurodegenerative diseases. The balance between NGF receptors may explain the contradictory biological activities of proNGF. However, the specific role of the two main proNGF variants is mostly unexplored. proNGF-A is prevalently expressed in healthy brain, while proNGF-B content increases in the neuro-degenerating brain. Recently we have investigated in vitro the biological action of native mouse proNGF variants. To gain further insights into the specific functions of the two proNGFs, here we intranasally delivered mouse-derived proNGF-A and proNGF-B to the brain parenchyma of healthy and diabetic rats, the latter characterized by dysfunction in spatial learning and memory, in the septo-hippocampal circuitry and by relative increase in proNGF-B hippocampal levels. Exogenous proNGF-B induces depression of hippocampal DG-LTP and impairment of hippocampal neurogenesis in healthy animals, with concomitant decrease in basal forebrain cholinergic neurons and cholinergic fibers projecting to the hippocampus. proNGF-A, while ineffective in healthy animals, rescues the diabetes-induced impairment in DG-LTP and hippocampal neurogenesis, promoting the concomitant recovery of the basal forebrain cholinergic phenotype. Our experimental evidences suggest that the balance between different proNGFs may influence the development and progression of neurodegenerative diseases.
AB - Pro-nerve growth factor (proNGF) is the predominant form of NGF in the brain and its levels increase in neurodegenerative diseases. The balance between NGF receptors may explain the contradictory biological activities of proNGF. However, the specific role of the two main proNGF variants is mostly unexplored. proNGF-A is prevalently expressed in healthy brain, while proNGF-B content increases in the neuro-degenerating brain. Recently we have investigated in vitro the biological action of native mouse proNGF variants. To gain further insights into the specific functions of the two proNGFs, here we intranasally delivered mouse-derived proNGF-A and proNGF-B to the brain parenchyma of healthy and diabetic rats, the latter characterized by dysfunction in spatial learning and memory, in the septo-hippocampal circuitry and by relative increase in proNGF-B hippocampal levels. Exogenous proNGF-B induces depression of hippocampal DG-LTP and impairment of hippocampal neurogenesis in healthy animals, with concomitant decrease in basal forebrain cholinergic neurons and cholinergic fibers projecting to the hippocampus. proNGF-A, while ineffective in healthy animals, rescues the diabetes-induced impairment in DG-LTP and hippocampal neurogenesis, promoting the concomitant recovery of the basal forebrain cholinergic phenotype. Our experimental evidences suggest that the balance between different proNGFs may influence the development and progression of neurodegenerative diseases.
KW - Cholinergic system
KW - Dentate-gyrus long-term potentiation (DG-LTP)
KW - Diabetes
KW - Hippocampal neurogenesis
KW - Rat
KW - pro nerve growth factor (proNGF)
KW - Cholinergic system
KW - Dentate-gyrus long-term potentiation (DG-LTP)
KW - Diabetes
KW - Hippocampal neurogenesis
KW - Rat
KW - pro nerve growth factor (proNGF)
UR - http://hdl.handle.net/10807/161326
U2 - 10.1016/j.neuropharm.2020.108223
DO - 10.1016/j.neuropharm.2020.108223
M3 - Article
SN - 0028-3908
VL - 176
SP - N/A-N/A
JO - Neuropharmacology
JF - Neuropharmacology
ER -